Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian W Bigger

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 19, 2020
Dual Purpose Vectors for Rare Neurological DiseasesBrian W Bigger
Neural Regeneration Research|March 17, 2023
Gene-modified neural progenitor cells for the treatment of neuropathic lysosomal storage diseasesOriana Mandolfo, Brian W Bigger
Journal of Neurochemistry|November 20, 2018
The role of innate immunity in mucopolysaccharide diseasesHelen Parker, Brian W Bigger
Discovery Medicine|April 25, 2014
Novel approaches and mechanisms in hematopoietic stem cell gene therapyBrian W Bigger, Robert F Wynn
Frontiers in Molecular Biosciences|September 29, 2022
Delivering gene therapy for mucopolysaccharide diseasesShaun R Wood, Brian W Bigger
Molecular Genetics and Metabolism|July 20, 2023
Phenotypic characterisation of the Mucopolysaccharidosis Type I (MPSI) Idua-W392X mouse model reveals increased anxiety-related traits in female miceTereza Andreou, Yuko Ishikawa-Learmonth, Brian W Bigger
Best Practice & Research. Clinical Endocrinology & Metabolism|May 20, 2015
The role of antibodies in enzyme treatments and therapeutic strategiesBrian W Bigger, Muhammad Saif, Gabor E Linthorst
ACS Chemical Neuroscience|August 24, 2018
Delivering Hematopoietic Stem Cell Gene Therapy Treatments for Neurological Lysosomal DiseasesRebecca J Holley, Shaun R Wood, Brian W Bigger
Pharmaceutical Research|July 9, 2011
Trial and error: how the unclonable human mitochondrial genome was cloned in yeastBrian W Bigger, Ai-Yin Liao, Ana Sergijenko, et al.
International Journal of Molecular Sciences|May 14, 2022
Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?Claire Horgan, Simon A Jones, Brian W Bigger, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 19, 2020
Dual Purpose Vectors for Rare Neurological DiseasesBrian W Bigger
Neural Regeneration Research|March 17, 2023
Gene-modified neural progenitor cells for the treatment of neuropathic lysosomal storage diseasesOriana Mandolfo, Brian W Bigger
Journal of Neurochemistry|November 20, 2018
The role of innate immunity in mucopolysaccharide diseasesHelen Parker, Brian W Bigger
Discovery Medicine|April 25, 2014
Novel approaches and mechanisms in hematopoietic stem cell gene therapyBrian W Bigger, Robert F Wynn
Frontiers in Molecular Biosciences|September 29, 2022
Delivering gene therapy for mucopolysaccharide diseasesShaun R Wood, Brian W Bigger
Molecular Genetics and Metabolism|July 20, 2023
Phenotypic characterisation of the Mucopolysaccharidosis Type I (MPSI) Idua-W392X mouse model reveals increased anxiety-related traits in female miceTereza Andreou, Yuko Ishikawa-Learmonth, Brian W Bigger
Best Practice & Research. Clinical Endocrinology & Metabolism|May 20, 2015
The role of antibodies in enzyme treatments and therapeutic strategiesBrian W Bigger, Muhammad Saif, Gabor E Linthorst
ACS Chemical Neuroscience|August 24, 2018
Delivering Hematopoietic Stem Cell Gene Therapy Treatments for Neurological Lysosomal DiseasesRebecca J Holley, Shaun R Wood, Brian W Bigger
Pharmaceutical Research|July 9, 2011
Trial and error: how the unclonable human mitochondrial genome was cloned in yeastBrian W Bigger, Ai-Yin Liao, Ana Sergijenko, et al.
International Journal of Molecular Sciences|May 14, 2022
Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?Claire Horgan, Simon A Jones, Brian W Bigger, et al.
Pageof 7